文献速递疝与腹壁外科围术期管理与 ERAS

微创与开放腹股沟疝修补术后阿片类药物使用情况对比

Opioid utilization in minimally invasive versus open inguinal hernia repair.
PubMed 文献 · Surgery · 2019-06-20

本研究前瞻性纳入3个中心的阿片类药物初治成人腹股沟疝修补患者,比较开放与微创术后阿片类处方与消耗。195例完成调查(开放97例,微创98例),两组出院疼痛评分、阿片处方量及实际消耗均无显著差异,超过三分之一患者未使用阿片类药物,75%处方量未被使用。

要点

  • 开放与微创腹股沟疝修补术后阿片类处方量及消耗量无显著差异。
  • 超过三分之一患者术后未使用阿片类药物,75%处方量未被使用。
  • 对阿片初治患者,0至8片5mg羟考酮对多数人已足够。

核心结论

  • 开放与微创腹股沟疝修补术后阿片类药物使用临床相似,单侧与双侧修补亦无差异。

研究设计与样本

  • 前瞻性识别3个中心阿片初治成人腹股沟疝修补患者,出院后完成29题电话调查,共195例(开放97例,微创98例)。

主要发现

  • 开放组与微创组出院疼痛评分相似(2.3±1.7 vs 2.4±1.6,P=.80)。
  • 开放组与微创组出院获阿片处方比例相似(98% vs 91%,P=.06),处方量相似(155 vs 150 MME,P=.08)。
  • 开放组与微创组阿片消耗量无差异(15 vs 9 MME,P=.33),超过三分之一未使用阿片(38% vs 44%,P=.42)。
  • 双侧修补未增加阿片使用(单变量OR 1.23,P=.58)。
  • 低出院疼痛和正常BMI独立关联无需阿片;75%处方阿片未使用,仅12%患者处置了未使用阿片。

关键数值与推荐

  • 开放组年龄稍大(71 vs 65岁,P<.001),女性比例更低(3% vs 17%,P=.001),单侧修补比例更高(95% vs 52%,P<.001)。

临床怎么用

  • 对阿片初治腹股沟疝修补患者,出院可考虑开具0至8片5mg羟考酮。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Open inguinal hernia repair is thought to cause worse postoperative pain than minimally invasive surgery, and thus patients are often prescribed more opioids at discharge. This study evaluates opioid use in inguinal hernia repair patients to optimize discharge prescribing practices for this common procedure. METHODS: Opioid-naive adults undergoing open or minimally invasive surgery inguinal hernia repair were identified prospectively from 3 centers to complete a 29-question telephone interview after discharge as part of a larger initiative. Opioid prescription and consumption data were converted into morphine milligram equivalents and compared between minimally invasive surgery and open inguinal hernia repair. Univariate χ2, Fisher exact test, univariate, and multivariable logistic regression were used. RESULTS: Of 249 contacted patients, 195 (74%) completed the survey (n = 97 open, n = 98 minimally invasive surgery). Patients undergoing open inguinal hernia repair were slightly older (71 vs 65 years, P < .001) and less likely to be female (3% vs 17%, P = .001) than minimally invasive surgery patients. Open patients were more likely to have a unilateral inguinal hernia repair (95% open vs 52% minimally invasive surgery, P < .001). Discharge pain scores using the 10-point, patient-reported Numeric Pain Rating scale were similar (open 2.3 ± 1.7 vs minimally invasive surgery 2.4 ± 1.6; P = .80), and most patients were satisfied with postoperative pain control (open 86% vs minimally invasive surgery 95%; P = .13). Open inguinal hernia repair patients were just as likely to receive opioids at discharge as those undergoing minimally invasive surgery inguinal hernia repair (98% vs 91% minimally invasive surgery; P = .06) and were prescribed similar amounts of opioids (open 155 [IQR 113, 225] morphine milligram equivalents vs 150 [IQR 100, 210] minimally invasive surgery; P = .08). There was no difference in opioid use by approach (open 15 [IQR 0, 60] morphine milligram equivalents vs 9 [IQR 0, 50] minimally invasive surgery; P = .33). More than one-third of patients used no opioids (open 38% vs minimally invasive surgery 44%; P = .42). Bilateral repair was not associated with increased opioid use (univariate odds ratio 1.23, P = .58). On multivariable analysis, low discharge pain and normal body mass index were independently associated with needing no opioids at discharge. Overall, 75% of prescribed opioids remained unused at time of survey, yet only 12% of patients had disposed of unused opioids at the time of survey. CONCLUSION: Postdischarge opioid utilization was clinically similar between patients undergoing open and minimally invasive surgery inguinal hernia repair and those requiring unilateral or bilateral repair. Given that more than one-third of patients required no opioids after discharge, 0 to 8 tablets of 5 mg oxycodone is sufficient for most opioid-naive patients undergoing inguinal hernia repair.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Knight AW, Habermann EB, Ubl DS, et al. Opioid utilization in minimally invasive versus open inguinal hernia repair. Surgery. 2019. PMID: 31229314. doi:10.1016/j.surg.2019.05.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。